Benzinga | Nov 3, 2021 09:19AM EDT

Pacira BioSciences Q3 Adj. EPS $0.72 Beats $0.65 Estimate, Sales $127.72M Miss $130.38M Estimate

Pacira BioSciences (NASDAQ:PCRX) reported quarterly earnings of $0.72 per share which beat the analyst consensus estimate of $0.65 by 10.77 percent. This is a 5.88 percent increase over earnings of $0.68 per share from the same period last year. The company reported quarterly sales of $127.72 million which missed the analyst consensus estimate of $130.38 million by 2.04 percent. This is a 8.71 percent increase over sales of $117.48 million the same period last year.